Karen Akinsanya

Insider Reports History

Location
New York, NY
Signature
/s/ Donald Shum, as attorney-in-fact for Karen Akinsanya
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Karen Akinsanya:

Company Role Class Num Shares Value Price $ Report Date Ownership
Schrodinger, Inc. President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships Common Stock 69,956 $902,642 $12.90 05 Mar 2026 Direct
Schrodinger, Inc. President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships Stock Option (right to buy) 48,500 02 Mar 2026 Direct
Nautilus Biotechnology, Inc. Director Stock Option (Right to Buy) 45,000 23 Jun 2025 Direct

Insider Reports Filed by Karen Akinsanya

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SDGR Schrodinger, Inc. 05 Mar 2026 1 -$17,625 4 President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships 06 Mar 2026, 17:27
SDGR Schrodinger, Inc. 02 Mar 2026 5 -$26,454 4 President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships 03 Mar 2026, 16:31
NAUT Nautilus Biotechnology, Inc. 23 Jun 2025 1 $0 4 Director 25 Jun 2025, 16:36
SDGR Schrodinger, Inc. 14 Apr 2025 7 -$366,726 4 President of R&D, Therapeutics 15 Apr 2025, 16:31
SDGR Schrodinger, Inc. 03 Mar 2025 2 $0 4 President of R&D, Therapeutics 04 Mar 2025, 17:29
NAUT Nautilus Biotechnology, Inc. 14 Jun 2024 1 $0 4 Director 17 Jun 2024, 17:40
SDGR Schrodinger, Inc. 04 Mar 2024 1 $0 4 President of R&D, Therapeutics 05 Mar 2024, 16:44
NAUT Nautilus Biotechnology, Inc. 15 Jun 2023 1 $0 4 Director 16 Jun 2023, 19:51
SDGR Schrodinger, Inc. 09 Feb 2023 1 $0 4 President of R&D, Therapeutics 10 Feb 2023, 15:59
NAUT Nautilus Biotechnology, Inc. 15 Jun 2022 1 $0 4 Director 16 Jun 2022, 20:03
NAUT Nautilus Biotechnology, Inc. 30 Mar 2022 1 $0 4 Director 31 Mar 2022, 18:16
NAUT Nautilus Biotechnology, Inc. 30 Mar 2022 0 $0 3 Director 31 Mar 2022, 18:13
SDGR Schrodinger, Inc. 09 Feb 2022 1 $0 4 EVP, Chief Biomedical Scientist, Head of Discovery R&D 09 Feb 2022, 20:14
SDGR Schrodinger, Inc. 15 Oct 2021 3 -$71,614 4 EVP, Chief Biomedical Scientist, Head of Discovery R&D 19 Oct 2021, 17:00
SDGR Schrodinger, Inc. 15 Sep 2021 3 -$79,165 4 EVP, Chief Biomedical Scientist, Head of Discovery R&D 16 Sep 2021, 17:01
SDGR Schrodinger, Inc. 16 Aug 2021 8 -$1,775,022 4 EVP, Chief Biomedical Scientist, Head of Discovery R&D 17 Aug 2021, 17:00
SDGR Schrodinger, Inc. 07 Jun 2021 7 -$1,187,637 4 EVP, Chief Biomedical Scientist, Head of Discovery R&D 09 Jun 2021, 17:00